Jacobs & Co. CA Has $220,000 Position in UnitedHealth Group Incorporated (NYSE:UNH)

Jacobs & Co. CA cut its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 12.6% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 459 shares of the healthcare conglomerate’s stock after selling 66 shares during the period. Jacobs & Co. CA’s holdings in UnitedHealth Group were worth $220,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of the company. BlackRock Inc. increased its stake in shares of UnitedHealth Group by 0.7% in the first quarter. BlackRock Inc. now owns 74,928,539 shares of the healthcare conglomerate’s stock valued at $35,410,478,000 after buying an additional 509,633 shares during the period. Wellington Management Group LLP grew its position in shares of UnitedHealth Group by 0.6% in the 1st quarter. Wellington Management Group LLP now owns 24,079,140 shares of the healthcare conglomerate’s stock valued at $11,379,561,000 after buying an additional 140,312 shares during the last quarter. Geode Capital Management LLC raised its holdings in UnitedHealth Group by 1.4% during the 1st quarter. Geode Capital Management LLC now owns 17,101,395 shares of the healthcare conglomerate’s stock worth $8,063,262,000 after purchasing an additional 242,959 shares during the last quarter. Morgan Stanley lifted its holdings in UnitedHealth Group by 13.8% in the fourth quarter. Morgan Stanley now owns 15,635,038 shares of the healthcare conglomerate’s stock valued at $8,289,386,000 after buying an additional 1,893,192 shares during the period. Finally, Moneta Group Investment Advisors LLC grew its holdings in UnitedHealth Group by 100,076.4% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock worth $6,268,753,000 after acquiring an additional 11,812,017 shares during the period. Institutional investors own 85.69% of the company’s stock.

UnitedHealth Group Stock Down 0.1 %

Shares of UnitedHealth Group stock opened at $486.06 on Tuesday. The company’s fifty day simple moving average is $492.05 and its two-hundred day simple moving average is $486.73. The company has a market cap of $450.24 billion, a P/E ratio of 21.75, a PEG ratio of 1.43 and a beta of 0.66. The company has a current ratio of 0.80, a quick ratio of 0.80 and a debt-to-equity ratio of 0.68. UnitedHealth Group Incorporated has a 12-month low of $445.68 and a 12-month high of $558.10.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Friday, July 14th. The healthcare conglomerate reported $6.14 EPS for the quarter, topping the consensus estimate of $5.92 by $0.22. UnitedHealth Group had a net margin of 6.06% and a return on equity of 26.72%. The business had revenue of $92.90 billion for the quarter, compared to analyst estimates of $90.97 billion. During the same quarter in the previous year, the firm posted $5.57 earnings per share. UnitedHealth Group’s quarterly revenue was up 15.6% on a year-over-year basis. Research analysts anticipate that UnitedHealth Group Incorporated will post 24.83 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 19th. Investors of record on Monday, September 11th will be issued a $1.88 dividend. The ex-dividend date of this dividend is Friday, September 8th. This represents a $7.52 annualized dividend and a yield of 1.55%. UnitedHealth Group’s payout ratio is 33.65%.

Insider Activity

In other news, CEO Andrew Witty sold 4,000 shares of the business’s stock in a transaction on Wednesday, July 19th. The shares were sold at an average price of $506.19, for a total transaction of $2,024,760.00. Following the completion of the sale, the chief executive officer now owns 78,573 shares of the company’s stock, valued at approximately $39,772,866.87. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.35% of the stock is owned by corporate insiders.

Analyst Ratings Changes

UNH has been the subject of a number of research reports. Royal Bank of Canada reduced their price target on shares of UnitedHealth Group from $592.00 to $572.00 and set an “outperform” rating for the company in a report on Monday, July 17th. SVB Securities dropped their target price on UnitedHealth Group from $625.00 to $560.00 in a report on Wednesday, June 14th. Wells Fargo & Company reduced their price objective on shares of UnitedHealth Group from $616.00 to $561.00 in a research report on Thursday, July 13th. Morgan Stanley reissued an “overweight” rating and issued a $587.00 price objective on shares of UnitedHealth Group in a research report on Friday, July 14th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $591.00 price objective on shares of UnitedHealth Group in a research report on Thursday, September 14th. Two equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $575.65.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.